Back

Advanced echocardiographic and multimodal insights into cardiac amyloidosis: predictors of heart failure and arrhythmic complications in ATTR and al subtypes

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiac amyloidosis (2) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Denise Cristiana Faro

Catania (Italy)

9 More presentations in this session

Presentation thumbnail
Discussant - Cardiac amyloidosis (2)
Presentation thumbnail
Right ventricular-pulmonary arterial coupling and outcomes in cardiac amyloidosis: Systematic review and meta-analysis
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Diagnostic yield of scintigraphy in suspected cardiac amyloidosis without left ventricular hypertrophy
Doctor N. Mora Ayestaran (Pamplona, Navarra, ES)
Abstract Slides Video
Presentation thumbnail
Early symptoms and medical history of patients with transthyretin amyloidosis cardiomyopathy: Results from the multi-country OverTTuRe study
Professor J. Smith (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Effectiveness and safety of edge-to-edge MItral vaLve repair in patients with significant mitraL rEgurgitatioN aNd cardIac ATTR amyloidosis: design and rationale of the MILLENNIAL trial
Doctor L. Hauptmann (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiac amyloidosis (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Echocardiographic differentiation of cardiac amyloidosis subtypes
thumbnail
Congress Presentation
Echocardiographic parameters as predictors of prognosis in cardiac amyloidosis: a systematic review and meta-analysis
thumbnail
Congress Presentation
A systematic review and meta-analysis of diagnostic performance of various echocardiographic parameters in cardiac amyloidosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources